Adherence to Dipeptidyl Peptidase-4 Inhibitors or Biguanidesand Associating Factors Related to Adherence in Patients with Type 2 Diabetes Mellitus: Observational, Cross-Sectional, Pharmacy-Based Survey
Not Applicable
Completed
- Conditions
- Type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000026466
- Lead Sponsor
- MSD K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1016
Inclusion Criteria
Not provided
Exclusion Criteria
Pregnant at any time of the study period Type 1 diabetes Prescribed DPP-4i (QW) or biguanide (other than BID with 1 pills at a time) Taking any other concomitant medications including prescribed oral drug or injectable drugs,during the last prescription period of DPP-4i (OD or BID) or biagunide BID, 1 pill at a time)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adherence measured as the numbers of days missed any dose(s) during the 7 days prior to the survey
- Secondary Outcome Measures
Name Time Method Adherence measured as the numbers of days missed any dose(s) during the 30 days prior to the survey